Volume XXII, Number 17 – December 7, 2015
In this issue:
AT THE END OF EVERY YEAR, IT’S ALWAYS SMART BUSINESS FOR EVERY LAB to peer into the future specifically to identify the best clinical and financial opportunities, and this issue of THE DARK REPORT delivers our overview of the most important healthcare macro trends to help you with your lab’s strategic planning. Also, we look at potential problems such as CMS’ efforts to collect market price data and FDA’s plans to regulate LDTs. Both initiatives are expected to have negative financial consequences for the nation’s medical laboratories and pathology groups.